NYSE:MET - Metlife Stock Price, Price Target & More

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife announced a quarterly dividend on Friday, July 6th. Stockholders of record on Monday, August 6th will be given a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 annualized dividend and a dividend yield of 3.80%. The ex-dividend date is Friday, August 3rd. View Metlife's Dividend History.

Metlife declared that its board has authorized a stock buyback plan on Tuesday, May 22nd 2018, which permits the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 3.1% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's management believes its shares are undervalued.

Metlife Inc (NYSE:MET) issued its quarterly earnings data on Wednesday, May, 2nd. The financial services provider reported $1.36 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.17 by $0.19. The financial services provider earned $15.15 billion during the quarter, compared to the consensus estimate of $15.52 billion. Metlife had a net margin of 6.48% and a return on equity of 8.70%. The company's revenue for the quarter was up .6% on a year-over-year basis. During the same period last year, the business posted $1.20 earnings per share. View Metlife's Earnings History.

17 brokers have issued 12 month target prices for Metlife's stock. Their forecasts range from $47.00 to $78.00. On average, they anticipate Metlife's stock price to reach $57.0714 in the next twelve months. This suggests a possible upside of 29.1% from the stock's current price. View Analyst Ratings for Metlife.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Metlife saw a decline in short interest in June. As of June 29th, there was short interest totalling 12,020,672 shares, a decline of 28.9% from the June 15th total of 16,900,543 shares. Based on an average daily volume of 7,086,353 shares, the days-to-cover ratio is currently 1.7 days. Currently, 1.4% of the company's stock are sold short. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), Prudential Public (PUK), AXA (AXAHY), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Torchmark (TMK).

News headlines about MET stock have trended positive this week, according to Accern Sentiment Analysis. Accern scores the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Metlife earned a media sentiment score of 0.43 on Accern's scale. They also assigned press coverage about the financial services provider an impact score of 45.66 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Metlife's stock is owned by a number of of retail and institutional investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (15.00%), NN Investment Partners Holdings N.V. (0.17%), Lodestar Investment Counsel LLC IL (0.04%), Gofen & Glossberg LLC IL (0.03%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.02%) and State of Alaska Department of Revenue (0.01%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including Gofen & Glossberg LLC IL, Gateway Investment Advisers LLC, Cullinan Associates Inc., Fjarde AP Fonden Fourth Swedish National Pension Fund, CENTRAL TRUST Co, Cibc Bank USA, Ledyard National Bank and Raymond James Trust N.A.. View Insider Buying and Selling for Metlife.

MET stock was acquired by a variety of institutional investors in the last quarter, including Farmers Trust Co., DAVENPORT & Co LLC, NN Investment Partners Holdings N.V., Addenda Capital Inc., State of Alaska Department of Revenue, IFM Investors Pty Ltd, CHURCHILL MANAGEMENT Corp and DnB Asset Management AS. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $44.20.

Metlife has a market capitalization of $44.93 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.